Novelion Therapeutics Inc. (NVLN) tumbled -6.72% or -0.06 to $0.77. It is nearly 203294 shares traded, which is 23.78% compare to the average total volume 854818. The market cap of NVLN is $14.30 million. The year to date change is -81.9%. The 52 week price range is from $0.75 to $5.87. Price of NVLN have changed -1.63% during last week. It have changed -56.05% over last month, -76.32% over last 3 months, -81.22% over last 6 months and -83.34% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVLN is 2.44. It is 216.88% above current price. The 200-day Moving Averages for NVLN is 3.59. It is 366.23% above current price. The 52-week High is 5.87. It is 662.34% from the current price. The 52-week Low is 0.75. It is -2.60% from current price.
There are some statistics of NVLN. It is has market cap $14.30 million. The share outstanding is 18.56 million. The average volume is 854818. The revenue is 28.67M. The gross profit is -836000. The percent of top 15 Institution holding is 120.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVLN is -657.09%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVLN is -35.46%.